Pediatr. praxi. 2026;27(3):174-176 | DOI: 10.36290/ped.2026.027

Nutritional support for preterm infants after discharge: indications for interventions and the role of iron supplementation in comprehensive care

MUDr. Jiří Dušek, Ph.D., MHA1, 2, MUDr. Lenka Nedvědová1, MUDr. Jana Dušková1, 3
1 Neonatologické oddělení, Nemocnice České Budějovice, a. s.
2 Zdravotně sociální fakulta, Jihočeská univerzita v Českých Budějovicích
3 University Hospital Umea, Sweden

Nutrition after discharge from the neonatal intensive care unit represents an important period influencing the subsequent growth and neurodevelopment of preterm infants. Infants born before 32 weeks of gestation or with very low birth weight remain at increased risk of postnatal growth restriction and nutritional deficiencies. This article summarizes the main indications for nutritional interventions after hospital discharge, with emphasis on growth monitoring and the role of iron supplementation as part of comprehensive post-discharge care. A practical framework for follow-up and nutritional management in outpatient pediatric practice is also discussed.

Keywords: preterm infant, post-discharge nutrition, growth monitoring, iron supplementation, ferritin, outpatient care.

Accepted: June 22, 2026; Published: July 1, 2026  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Dušek J, Nedvědová L, Dušková J. Nutritional support for preterm infants after discharge: indications for interventions and the role of iron supplementation in comprehensive care. Pediatr. praxi. 2026;27(3):174-176. doi: 10.36290/ped.2026.027.
Download citation

References

  1. Haiden N, Luque V, Domellöf M, et al. Assessment of growth status and nutritional management of prematurely born infants after hospital discharge: a position paper of the ESPGHAN Nutrition Committee. J Pediatr Gastroenterol Nutr. 2025;81(2):421-441. Go to original source...
  2. Embleton ND, Moltu SJ, Lapillonne A, et al. Enteral nutrition in preterm infants (2022): a position paper from the ESPGHAN Committee on Nutrition and invited experts. J Pediatr Gastroenterol Nutr. 2023;76(2):248-268. Go to original source... Go to PubMed...
  3. Dušek J, Sjöström ES, Zamir IN. Implementation of nutritional care bundle is associated with improved growth in preterm infants born before 32 gestational weeks. Early Hum Dev. 2024;199:106151. Go to original source... Go to PubMed...
  4. Dušek J. Důsledky změny systému výživy novorozenců narozených pod 32. gestační týden na morbiditu a vývoj antropometrických parametrů až do 2 let korigovaného věku. Výživa a zdraví. 2025;29:30.
  5. Berglund S, Domellöf M. Children's iron needs and how we best can protect the child's brain. Lakartidningen. 2014;111(11):460-463.
  6. Berglund SK, Domellöf M. Iron deficiency in infancy: current insights. Curr Opin Clin Nutr Metab Care. 2021; 24(3):240-245. Go to original source...
  7. Georgieff MK. Long-term brain and behavioral consequences of early iron deficiency. Nutr Rev. 2011;69(Suppl 1):S43-S48. Go to original source...
  8. Siddappa AM, Georgieff MK, Wewerka S, et al. Iron deficiency alters auditory recognition memory in newborn infants of diabetic mothers. Pediatr Res. 2004;55(2):1034-1041. Go to original source... Go to PubMed...
  9. Franz AR, Mihatsch WA, Sander S, et al. Prospective randomized trial of early iron supplementation in infants with birth weight
  10. Georgieff MK. Long-term brain and behavioral consequences of early iron deficiency. Nutr Rev. 2011;69(Suppl 1):S43-S48. Go to original source...
  11. Beard JL. Why iron deficiency is important in infant development. J Nutr. 2008;138(12):2534-2536. Go to original source...
  12. Lozoff B, Beard J, Connor J, et al. Long-lasting neural and behavioral effects of iron deficiency in infancy. Nutr Rev. 2006;64(Suppl 2):S34-S43. Go to original source... Go to PubMed...
  13. Rao R, Georgieff MK. Iron in fetal and neonatal nutrition. Semin Fetal Neonatal Med. 2009;14(3):177-182. Go to original source... Go to PubMed...
  14. Rouault TA. Iron metabolism in the CNS: implications for neurodegenerative diseases. Nat Rev Neurosci. 2013;14. Go to original source... Go to PubMed...




Pediatrics for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.